首页> 外文期刊>Innovations: technology and techniques in cardiothoracic and vascular surgery >Veno-Venous Extracorporeal Membrane Oxygenation Use in the Treatment of Bleomycin Pulmonary Toxicity
【24h】

Veno-Venous Extracorporeal Membrane Oxygenation Use in the Treatment of Bleomycin Pulmonary Toxicity

机译:静脉静脉体外膜氧合用途治疗肺霉素肺毒性

获取原文
获取原文并翻译 | 示例
       

摘要

Pulmonary toxicity is a devastating complication of bleomycin chemotherapy. This insult is likely exacerbated by the free radical injury induced by high inspired oxygen content, which is required to support these patients. Traditional treatment consists of high-dose corticosteroids. We report the case of a 45-year-old man who developed bleomycin pulmonary toxicity, which failed to respond to treatment with high-dose corticosteroids. We used protective mechanical ventilatory settings while supported on veno-venous extracorporeal membrane oxygenation using a bicaval dual-lumen, single cannula system to allow for lung recovery. This case demonstrates the feasibility of using veno-venous extracorporeal membrane oxygenation to treat bleomycin pulmonary toxicity in a patient who has failed traditional therapy.
机译:肺部毒性是博莱霉素化疗的破坏性并发症。 这种侮辱可能会加剧由高灵感氧含量引起的自由基损伤,这是支持这些患者所必需的。 传统治疗由高剂量皮质类固醇组成。 我们举报了一个45岁男性开发了博莱霉素肺毒性的人,这未能用高剂量皮质类固醇响应治疗。 我们使用了保护机械通气设置,同时使用双腔双腔,单套管系统来支持静脉体外膜氧合,以允许肺部回收。 本例证明了使用静脉体外膜氧合的可行性,以治疗失败的传统治疗的患者患者肺霉素肺毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号